Abbeville Area Podiatry Group Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 901 W Greenwood St Ste 1, Abbeville, SC 29620 Phone: 864-366-9681 Fax: 864-366-2896 |
News Archive
Further helping to secure public health, a second round of revised quality standards for the widely used blood thinner heparin became effective today, the U.S. Pharmacopeial (USP) Convention announced. Working closely with the Food and Drug Administration (FDA), the pharmaceutical industry, and other regulatory and scientific bodies, USP started initial revisions in 2008 after adverse reactions and deaths resulted from heparin intentionally adulterated with over-sulfated chondroitin sulfate (OSCS).
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. represented its client, Paratek Pharmaceuticals, Inc. in a worldwide licensing agreement with Novartis for its late-stage antibiotic, PTK 0796.
The University of Texas Health Science Center at Houston School of Nursing will send its first participant to the Rwanda Human Resources for Health Program in January 2014. The program is part of a seven-year, $150 million initiative championed by former President Bill Clinton and Rwanda President Paul Kagame.
Mayo Clinic researchers, along with national and global collaborators, have developed a potential test for Machado-Joseph disease, or spinocerebellar ataxia type 3 (SCA3) ? a disease that has no cure.
A cancer tumor's ability to mutate allows it to escape from chemotherapy and other attempts to kill it. So, encouraging mutations would not be a logical path for cancer researchers.
› Verified 5 days ago